Key Takeaway
Creatine is safe with all GLP-1 medications and may help preserve muscle during weight loss. Review the complete evidence on combining creatine with GLP-1 therapy.
Yes, creatine is safe to take with all GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda). There are no drug interactions, and creatine may be one of the most strategic supplements for GLP-1 patients because it helps protect muscle mass during weight loss.
Lean mass loss by GLP-1 drug in clinical trials
Every GLP-1 medication faces the same body composition challenge. Here is what the clinical data shows for lean mass loss as a percentage of total weight lost:
- Semaglutide 2.4 mg (Wegovy): ~39% lean mass loss in STEP 1[1]
- Tirzepatide 15 mg (Zepbound): ~33% lean mass loss in SURMOUNT-1[2]
- Liraglutide 3.0 mg (Saxenda): ~35% lean mass loss in SCALE trials
For context, dietary weight loss without exercise typically results in 20-30% lean mass loss, and weight loss with resistance training can reduce lean mass loss to 10-15% of total weight. The gap between these numbers represents a real opportunity for GLP-1 patients who add strength training and creatine to their regimen.
Evidence on creatine for muscle during weight loss
Creatine is the most researched sports supplement in history. The International Society of Sports Nutrition reviewed over 500 studies in their 2017 position stand and concluded that creatine monohydrate is safe, effective, and beneficial for increasing lean body mass when combined with resistance training.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
During caloric restriction (which GLP-1 medications create through appetite suppression), creatine provides specific advantages:
- Maintains training intensity when energy intake is low
- Supports muscle protein synthesis through improved cell hydration
- Reduces markers of muscle protein breakdown during energy deficit
- Improves recovery quality, enabling more frequent training
Muscle preservation steps for GLP-1 patients
Based on current evidence, the optimal approach for GLP-1 patients concerned about lean mass:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- Resistance training: 2-4 sessions per week, prioritizing compound movements (squats, deadlifts, presses, rows)
- Protein: 1.0-1.2 g/kg body weight daily, distributed across 3-4 meals with 25-40g per meal
- Creatine: 5 grams creatine monohydrate daily, taken consistently
- Hydration: At least 80-100 oz water daily
- Sleep: 7-9 hours nightly for optimal recovery and hormone balance
Frequently Asked Questions
Does creatine interact with GLP-1 medications?
Yes. Creatine monohydrate has no interactions with any GLP-1 receptor agonist, including semaglutide, tirzepatide, liraglutide, and dulaglutide. They work through entirely separate biological pathways.
What drives muscle loss during GLP-1 treatment?
All weight loss, regardless of method, includes some lean mass loss. GLP-1 medications create a caloric deficit through appetite suppression. In that deficit, your body metabolizes both fat and muscle tissue for energy. Clinical trials show 25-40% of GLP-1 weight loss can be lean mass without countermeasures.
What is the best way to protect muscle on GLP-1 drugs?
The evidence-based approach combines three elements: resistance training 2-4 times weekly, high protein intake (1.0-1.2 g/kg body weight daily), and creatine monohydrate supplementation (5g daily). Together, these give your muscles the stimulus, building blocks, and energy they need to resist breakdown.
Can creatine make kidney lab results look different?
Creatine doesn't cause kidney damage in people with healthy kidneys, whether or not they take GLP-1 medications. It can slightly improve serum creatinine levels, which is a lab artifact, not a sign of kidney harm. Inform your doctor about creatine use before any blood work.
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
How clinicians guide supplements, exercise and nutrition on GLP-1 treatment
At FormBlends, we don't just prescribe GLP-1 medications and send you on your way. Our physicians provide thorough guidance on supplementation, exercise, and nutrition to help you lose fat while protecting the muscle that keeps your metabolism strong.
Sources
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183.
- Friedrichsen M et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes, Obesity and Metabolism. 2021.
- Blundell J et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism. 2017.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →